Navigating The Rapids: Understanding the 'Waterfall Mechanism' in Section 53 of IBC, 2016

What is the Waterfall Mechanism?

Section 53 of the Insolvency and Bankruptcy Code, 2016 establishes a strict priority order for the distribution of a company's assets during liquidation. Known as the "waterfall mechanism" for the sequential manner in which proceeds flow to different classes of creditors, this provision determines who gets paid first — and how much — when a company is wound up.

For pharmaceutical corporations, which often have complex creditor relationships including raw material suppliers, equipment lessors, and regulatory deposit obligations, understanding this priority order is essential for credit risk management and recovery strategy.

The Priority Waterfall Under Section 53

Relevance for Pharmaceutical Corporations

Pharmaceutical companies frequently appear as operational creditors in insolvency proceedings of their customers — hospitals, distributors, and retail pharmacy chains. Understanding their position in the Section 53 waterfall helps pharma companies assess recovery prospects and take proactive steps during the Corporate Insolvency Resolution Process (CIRP) to maximise their recoveries.

Advocate Srijan Tiwari's cross-domain expertise in both pharmaceutical law and insolvency proceedings makes him uniquely positioned to advise pharmaceutical and cosmetics corporations on their creditor rights in insolvency situations — complementing his primary practice in drug law litigation.